loader2
Partner With Us NRI

Artemis Medicare Services Ltd share Price Today

Company details

177.05
183.85
72.30
196.95
6M Return 13.83%
1Y Return 142.83%
Mkt Cap.(Cr) 2,438.03
Volume 68,953
Div Yield 0.24%
OI
-
OI Chg %
-
Volume 68,953

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Healthcare facilities company Artemis Medicare Services announced Q1FY24 results:

  • Net revenue from operations increased by 25.3% to Rs 2,095 million from Rs 1,672 million
  • EBITDA increased by 35.4% to Rs 292 million from Rs 215 million with a margin of 13.9%
  • PBT increased by 23.5% to Rs 131 million from Rs 106 million with a margin of 6.3%
  • Net debt of Rs 2,105 million as on June 30, 2023; net debt/shareholder’s Equity of 0.50x

Announcing the results, Dr. Devlina Chakravarty, Managing Director of Artemis Medicare Services, commented, “We are delighted to announce the financial results of Q1FY24. This is one of the best-ever quarterly performances and gives a promising start to the new fiscal year, despite it being a seasonally weak quarter. Our efforts for improving revenue realisations, finetuning efficiencies, and optimizing costs are showing results in both revenues and profitability.

Occupancy has successfully ramped up in the new tower which was operationalised towards the end of FY22. We look forward to the third tower, which will operationalise by early FY25 as per plan, as it will enhance our performance further.

During the quarter we have added a new hospital in Gurgaon under the Artemis Lite brand. The positive response that we have received for this hospital in a short period yet again stands as testimony to the concept of neighbourhood multi-specialty hospitals which we introduced last year.

Additionally, we have started the first of the two hospitals in Mauritius under the O&M agreement. In India, our subsidiary, Artemis Cardiac Care, and the homecare vertical, Solace by Artemis, both continue to make their impact beyond the main hospital footprint.

Overall Artemis continues its pursuit of long-term sustainable growth in the Delhi NCR region, through the combination of asset-light developments and acquisitions.”

 

 

Result PDF

View Other Company Results

Artemis Medicare Services Ltd shares SWOT Analysis

Strengths (8)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Rising Net Cash Flow and Cash from Operating activity
  • Effectively using its capital to generate profit - RoCE improving in last 2 years

Weakness (0)

Data not found

Opportunity (1)

  • Highest Recovery from 52 Week Low

Threats (2)

  • Companies with growing costs YoY for long term projects
  • High PE (PE > 40)

Resistance and support

R1 183.2
R2 186.9
R3 190.0
Pivot

180.12

S1 176.4
S2 173.3
S3 169.6
EMA SMA
177.5
174.5
169.9
153.7
175.5
173.4
175.2
156.7
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
Name Category Shares
CONSTRUCTIVE FINANCE PRIVATE LIMITED PROMOTER 68.03%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Artemis Medicare Services Ltd Stocks COMPARISON

Financials( in Cr) Artemis Medicare Services Ltd Apollo Hospitals Enterprise Ltd Max Healthcare Institute Ltd Global Health Ltd Fortis Healthcare Ltd
Price 179.45 6,334.75 817.95 1,386.50 441.10
% Change -0.88 0.50 -1.85 0.45 1.19
Mcap Cr 2,438.03 91,084.20 79,490.51 37,217.40 33,301.20
Revenue TTM Cr 737.43 16,612.50 4,831.37 2,694.25 6,537.06
Net Profit TTM Cr 38.01 887.50 1,103.51 326.08 632.98
PE TTM 54.07 115.00 76.53 81.82 61.56
1 Year Return 142.83 44.41 73.55 185.08 66.52
ROCE 12.41 14.16 13.85 16.49 7.51
ROE 12.10 15.04 16.12 16.13 6.79
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 403.15 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 22,701.14 -977.22
LAST 3M 84,025.63 45,820.51
LAST 6M 131,642.99 78,083.44
LAST 12M 206,655.58 204,047.57
Artemis Medicare Services Limited - Shareholders meeting

Apr 12, 2024 l NSE Announcement

Artemis Medicare Services Limited - Shareholders meeting

Apr 10, 2024 l NSE Announcement

Date Action Type Ratio
Jul 14, 2023 Dividend 45

Artemis Medicare Services Ltd Information

Stock PE (TTM)
54.07
Promoter Holding
68.03%
Book Value
25.8631
ROCE
12.41%
ROE
12.1%
Description
  • Artemis Health Institute is a healthcare venture launched by the Promoters of the Apollo Tyres Group. Since incorporated in 18 May 2004, the Group is engaged in the business of managing and operating of multi specialty hospitals and commenced its commercial operation by setting up Artemis Hospital (formerly Artemis Health Institute) at Gurugram on 16 July 2007. Artemis Hospital (a unit of Artemis Medicare Services Limited) is spread across 9 acres, is a 395 bed; state-of-the-art multi-speciality hospital located in Gurugram, India. Designed as one of the most advanced in India, the Company provides a depth of expertise in the spectrum of advanced medical & surgical interventions, comprehensive mix of inpatient and outpatient services. Artemis Hospital diligently adheres to meet the highest standards of clinical outcomes which it has set for itself in various specialties. The Hospital is the first to introduce Masimo technology based on Clinical Surveillance System and equipped with North India`s first M6 Cyber knife having successfully performed over 1000 procedures. The hospital has an impeccable track record and high success rates even in surgeries of high complexity such as transplants, cardiac care and oncology. This unwavering focus on clinical excellence enables Artemis Hospitals to continuously assess the quality of care provided to patients and allows to objectively measure the consistency and success of healthcare delivery services. In addition to the focus on clinical excellence, the Hospital ensures that medical professionals and other staff are periodically trained on the newest techniques and procedures in the medical field on a periodic and continuous basis. The Hospital has put modern technology in the hands of renowned doctors from India and abroad as well to set new standards in healthcare. The medical practices and procedures followed in the hospital are research oriented and bench-marked against the best in the world. Top-notch services, in a warm, open patient centric environment, clubbed with affordability, has made the Unit one of the most revered hospitals in the country. Artemis Hospital received accreditation from the Joint Commission International, USA (JCI) for meeting international healthcare quality standards for patient care and management. The Hospital in Gurugram was accredited with JCI and NABH (National Accreditation Board for Hospitals) within 3 years of start up. The hospital also received Green OT certification from Bureau Veritas.

Registered Address

Plot No 14 Sector 20, Dwarka, New Delhi, Delhi, 110075

Tel : 91-11-4511111
Email : investor:artemishospitals.com
Website : http://www.artemishospitals.com
Registrar

Alankit Assignments Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 542919
NSE Code : ARTEMISMED
Book Closure Date (Month) :
BSE Group : B
ISIN : INE025R01021

FAQ’s on Artemis Medicare Services Ltd Shares

You can buy Artemis Medicare Services Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Artemis Medicare Services Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Apr 16, 2024 03:57 PM the closing price of Artemis Medicare Services Ltd was ₹ 179.45.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Apr 16, 2024 03:57 PM, the market cap of Artemis Medicare Services Ltd stood at ₹ 2,438.03.

The latest PE ratio of Artemis Medicare Services Ltd as of Apr 16, 2024 03:57 PM is 54.07

The latest PB ratio of Artemis Medicare Services Ltd as of Apr 16, 2024 03:57 PM is 0.14

The 52-week high of Artemis Medicare Services Ltd share price is ₹ 196.95 while the 52-week low is ₹ 72.30

Download Our

Download App
market app